From the Guidelines
Pharmaceutical grade methamphetamine, marketed under the brand name Desoxyn, is FDA-approved for the treatment of attention deficit hyperactivity disorder (ADHD) and short-term treatment of obesity, and should be used as a last resort due to its high potential for abuse and dependence. For ADHD, typical dosing starts at 5 mg once or twice daily, potentially increasing to 20-25 mg daily divided into doses, as supported by the most recent evidence from 1. The medication works by increasing levels of dopamine and norepinephrine in the brain, improving focus and reducing hyperactivity in ADHD patients, while also suppressing appetite in obesity treatment.
Some key points to consider when prescribing Desoxyn include:
- Potential side effects, such as insomnia, decreased appetite, increased blood pressure, and risk of psychological dependence, as noted in 1 and 1
- Regular monitoring by a healthcare provider is essential during treatment, as emphasized in 1 and 1
- The medication is classified as a Schedule II controlled substance, indicating a high potential for abuse and dependence, as mentioned in 1 and 1
- Desoxyn is typically only prescribed when other treatments have failed, as suggested in 1 and 1
It is essential to carefully evaluate the patient's condition and medical history before initiating treatment with Desoxyn, and to closely monitor their response to the medication to minimize the risk of adverse effects. As stated in 1, stimulant medications, including methamphetamine, are associated with a range of adverse effects, which are generally acceptable as they are predominantly mild and/or temporary. However, it is crucial to consider the potential risks and benefits of treatment with Desoxyn, particularly in light of its high potential for abuse and dependence.
From the Research
Pharmaceutical Grade Methamphetamine
There are no research papers provided to directly answer the question about the use of pharmaceutical grade methamphetamine.
Available Information on Similar Substances
However, information is available on similar substances such as methylphenidate and amphetamine:
- Methylphenidate is used for the treatment of attention-deficit hyperactivity disorder (ADHD) and narcolepsy, as reported in studies 2, 3, 4.
- Amphetamine is also used for the treatment of ADHD and narcolepsy, with its pharmacological actions and clinical perspective discussed in 5.
- The abuse potential of methylphenidate has been assessed in nonhuman and human subjects, with results indicating that it may have abuse potential similar to other psychostimulants 6.